Article

BA.2 evasion of vaccine induced binding and functional non-neutralizing antibodies

2022-02-28

Abstract excerpt

The number of mutations in the omicron (B1.1.529) BA.1 variant of concern (VOC) led to an unprecedented evasion of vaccine induced immunity. However, despite the remarkable rise in global infections, severe disease and death did not increase proportionally, linked to persistent recognition of BA.1 by T cells and non-neutralizing opsonophagocytic antibodies. Yet, the emergence of a new sublineage, BA.2, that is mor...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ae37de79-5726-5d10-9018-9122b393f8ff
DOI: 10.1101/2022.02.25.22271511

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

BA.2 evasion of vaccine induced binding and functional non-neutralizing antibodiesDOI 10.1101/2022.02.25.22271511Read

Immune evasion of Omicron variants JN.1, KP.2, and KP.3 to the polyclonal and monoclonal antibodies from COVID-19 convalescents and vaccine recipients.Semantic proximity Read

Potent cross-reactive antibodies following Omicron breakthrough in vaccineesSemantic proximity Read

BNT162b2 induced neutralizing and non-neutralizing antibody functions against SARSCoV-2 diminish with ageSemantic proximity Read

Waning and boosting of antibody Fc-effector functions upon SARS-CoV-2 vaccinationSemantic proximity Read

Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after the third dose of BNT162b2 in healthy adolescentsSemantic proximity Read

BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variantsSemantic proximity Read

Waning and boosting of functional humoral immunity to SARS-CoV-2Semantic proximity Read

SARS-CoV-2 Omicron BA.2.12.1, BA.4, and BA.5 subvariants evolved to extend antibody evasionSemantic proximity Read

Slow waning of antibodies following a third dose of BNT162b2 in adults who had previously received two doses of inactivated vaccineSemantic proximity Read

Neutralizing antibodies against the SARS-CoV-2 Omicron variant BA.1 following homologous and heterologous CoronaVac or BNT162b2 vaccinationSemantic proximity Read

Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccinesSemantic proximity Read

Immune Response and Clinical Outcomes of BNT162b2 and mRNA1273 Fourth Dose COVID-19 Vaccines; Three Months Follow-upSemantic proximity Read